$GCTK

Glucotrack, Inc.

Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Rutherford, NJ

GCTK chart

What traders are saying about $GCTK

Latest posts

Glucotrack, Inc. news

Glucotrack, Inc. key financials

USD2025202420232022
Revenue––––
Net income-$19.4M-$22.6M-$7.1M-$4.4M
Diluted EPS$31.22$4106.00$34.18$0.29
Total assets (year end)$7.8M$5.9M$4.9M$2.4M
Cash and equivalents (year end)$7.4M$5.6M$4.5M$2.3M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

  • 8-K8-K
  • 8-K8-K
  • 8-K/A8-K/A
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • S-1S-1
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K

About Glucotrack, Inc.

Ticker
GCTK (Nasdaq)
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
Rutherford, NJ
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1506983
Former names
Integrity Applications, Inc.

Frequently asked questions

What exchange is Glucotrack, Inc. listed on?

Glucotrack, Inc. trades on the Nasdaq under the ticker symbol GCTK.

What industry is Glucotrack, Inc. in?

Glucotrack, Inc. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.

Where is Glucotrack, Inc. headquartered?

Glucotrack, Inc.'s business address on file with the SEC is in Rutherford, NJ.

When does Glucotrack, Inc.'s fiscal year end?

Glucotrack, Inc.'s fiscal year ends on December 31.

How much revenue did Glucotrack, Inc. report?

Glucotrack, Inc. reported $208,000 in revenue for calendar year 2019, according to its SEC filings.